Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

Author： Elias A.   Brancer M.   Budkowska A.   Pillot J.   Poynard T.   Maillard J.   Lazizi Y.   Dubreuil P.   Chaput J.C.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.3, 1995-01, pp. : 289-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

By Raz R.   Dagan R.   Gallil A.   Brill G.   Kassis I.   Koren R.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 207-211

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

By Leroux-Roels G.   Desombere I.   De Tollenaere G.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1724-1731

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines

By Leroux-Roels G.   Desombere I.   Cobbaut L.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1732-1736

Elsevier

Access to resources Recommend Favorite

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein

By Yamada T.   Iwabuki H.   Kanno T.   Tanaka H.   Kawai T.   Fukuda H.   Kondo A.   Seno M.   Tanizawa K.   Kuroda S.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3154-3163

Elsevier

Access to resources Recommend Favorite

Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene(R), a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products

By Pride M.W.   Bailey C.R.   Muchmore E.   Thanavala Y.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 543-550

Elsevier

Access to resources Recommend Favorite